Inhibition of the interactions between eosinophil cationic protein and airway epithelial cells by traditional Chinese herbs

BMC Systems Biology

Volumn 4, Issue SUPPL. 2, 2010, Pages

  Chang, Hao Teng ^a   Tseng, Louis J ^a   Hung, Ta Jen ^b   Kao, Blacky T ^a   Lin, Wei Yong ^a   Fan, Tan chi ^b   Chang, Margaret D ^b   Pai, Tun Wen ^c  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b NATIONAL TSING HUA UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN OCEAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIA (MICROORGANISMS); MAMMALIA;

EOSINOPHIL CATIONIC PROTEIN; HERBACEOUS AGENT; IMMUNOLOGIC FACTOR;

ARTICLE; CELL LINE; DRUG SCREENING; EPITHELIUM CELL; HUMAN; METABOLISM; SYSTEMS BIOLOGY;

CELL LINE; DRUG EVALUATION, PRECLINICAL; DRUGS, CHINESE HERBAL; EOSINOPHIL CATIONIC PROTEIN; EPITHELIAL CELLS; HUMANS; IMMUNOLOGIC FACTORS; SYSTEMS BIOLOGY;

EID: 77956797759     PISSN: None     EISSN: 17520509     Source Type: Journal    
DOI: 10.1186/1752-0509-4-8     Document Type: Article

References (29)

1. Wolthers OD. Eosinophil granule proteins in the assessment of airway inflammation in pediatric bronchial asthma. Pediatr Allergy Immunol 2003, 14:248-254. 10.1034/j.1399-3038.2003.00030.x, 12911500.
2. Makarov AA, Ilinskaya ON. Cytotoxic ribonucleases: molecular weapons and their targets. FEBS Lett 2003, 540:15-20. 10.1016/S0014-5793(03)00225-4, 12681476.
3. Rosenberg HF. RNase A ribonucleases and host defense: an evolving story. J Leukoc Biol 2008, 83:1079-1087. 2692241, 18211964, 10.1189/jlb.1107725.
4. Cheng GZ, Li JY, Li F, Wang HY, Shi GX. Human ribonuclease 9, a member of ribonuclease A superfamily, specifically expressed in epididymis, is a novel sperm-binding protein. Asian J Androl 2009, 11:240-251. 10.1038/aja.2008.30, 19137000.
5. Rosenberg HF, Ackerman SJ, Tenen DG. Human eosinophil cationic protein. Molecular cloning of a cytotoxin and helminthotoxin with ribonuclease activity. J Exp Med 1989, 170:163-176. 2189377, 2473157, 10.1084/jem.170.1.163.
6. Rosenberg HF. Recombinant human eosinophil cationic protein. Ribonuclease activity is not essential for cytotoxicity. J Biol Chem 1995, 270:7876-7881. 10.1074/jbc.270.35.20516, 7713881.
7. Huang YC, Lin YM, Chang TW, Wu SJ, Lee YS, Chang MD, Chen C, Wu SH, Liao YD. The flexible and clustered lysine residues of human ribonuclease 7 are critical for membrane permeability and antimicrobial activity. J Biol Chem 2007, 282:4626-4633. 10.1074/jbc.M607321200, 17150966.
8. Domachowske JB, Dyer KD, Bonville CA, Rosenberg HF. Recombinant human eosinophil-derived neurotoxin/RNase 2 functions as an effective antiviral agent against respiratory syncytial virus. J Infect Dis 1998, 177:1458-1464. 10.1086/515322, 9607820.
9. Mallorqui-Fernandez G, Pous J, Peracaula R, Aymami J, Maeda T, Tada H, Yamada H, Seno M, de Llorens R, Gomis-Ruth FX, Coll M. Three-dimensional crystal structure of human eosinophil cationic protein (RNase 3) at 1.75 A resolution. J Mol Biol 2000, 300:1297-1307. 10.1006/jmbi.2000.3939, 10903870.
10. Carreras E, Boix E, Navarro S, Rosenberg HF, Cuchillo CM, Nogues MV. Surface-exposed amino acids of eosinophil cationic protein play a critical role in the inhibition of mammalian cell proliferation. Mol Cell Biochem 2005, 272:1-7. 10.1007/s11010-005-4777-2, 16010966.
11. Carreras E, Boix E, Rosenberg HF, Cuchillo CM, Nogues MV. Both aromatic and cationic residues contribute to the membrane-lytic and bactericidal activity of eosinophil cationic protein. Biochemistry 2003, 42:6636-6644. 10.1021/bi0273011, 12779318.
12. Fan TC, Chang HT, Chen IW, Wang HY, Chang MD. A heparan sulfate-facilitated and raft-dependent macropinocytosis of eosinophil cationic protein. Traffic 2007, 8:1778-1795. 10.1111/j.1600-0854.2007.00650.x, 17944807.
13. Domachowske JB, Dyer KD, Adams AG, Leto TL, Rosenberg HF. Eosinophil cationic protein/RNase 3 is another RNase A-family ribonuclease with direct antiviral activity. Nucleic Acids Res 1998, 26:3358-3363. 147714, 9649619, 10.1093/nar/26.14.3358.
14. Lehrer RI, Szklarek D, Barton A, Ganz T, Hamann KJ, Gleich GJ. Antibacterial properties of eosinophil major basic protein and eosinophil cationic protein. J Immunol 1989, 142:4428-4434.
15. Molina HA, Kierszenbaum F, Hamann KJ, Gleich GJ. Toxic effects produced or mediated by human eosinophil granule components on Trypanosoma cruzi. Am J Trop Med Hyg 1988, 38:327-334.
16. Torrent M, de la Torre BG, Nogues VM, Andreu D, Boix E. Bactericidal and membrane disruption activities of the eosinophil cationic protein are largely retained in an N-terminal fragment. Biochem J 2009, 421:425-434. 10.1042/BJ20082330, 19450231.
17. Venge P. Monitoring the allergic inflammation. Allergy 2004, 59:26-32. 10.1046/j.1398-9995.2003.00386.x, 14674929.
18. Winterkamp S, Raithel M, Hahn EG. Secretion and tissue content of eosinophil cationic protein in Crohn's disease. J Clin Gastroenterol 2000, 30:170-175. 10.1097/00004836-200003000-00009, 10730922.
19. Magnaval JF, Faufingue JH, Morassin B, Fabre R. Eosinophil cationic protein, specific IgE and IgG4 in human toxocariasis. J Helminthol 2006, 80:417-423. 10.1017/JOH2006369, 17125552.
20. Ramos AL, Discipio RG, Ferreira AM. Eosinophil cationic protein damages protoscoleces in vitro and is present in the hydatid cyst. Parasite Immunol 2006, 28:347-355. 10.1111/j.1365-3024.2006.00842.x, 16879306.
21. Gleich GJ. Mechanisms of eosinophil-associated inflammation. J Allergy Clin Immunol 2000, 105:651-663. 10.1067/mai.2000.105712, 10756213.
22. Chang KC, Lo CW, Fan TC, Chang MD, Shu CW, Chang CH, Chung CT, Fang SL, Chao CC, Tsai JJ, Lai YK. TNF-alpha mediates eosinophil cationic protein-induced apoptosis in BEAS-2B cells. BMC Cell Biol 11:6. 2819994, 20089176, 10.1186/1471-2121-11-6.
23. Wu CM, Chang HT, Chang MD. Membrane-bound carboxypeptidase E facilitates the entry of eosinophil cationic protein into neuroendocrine cells. Biochem J 2004, 382:841-848. 1133959, 15233624, 10.1042/BJ20040894.
24. Fan TC, Fang SL, Hwang CS, Hsu CY, Lu XA, Hung SC, Lin SC, Chang MD. Characterization of molecular interactions between eosinophil cationic protein and heparin. J Biol Chem 2008, 283:25468-25474. 10.1074/jbc.M803516200, 18593710.
25. Pandha HS, Heinemann L, Simpson GR, Melcher A, Prestwich R, Errington F, Coffey M, Harrington KJ, Morgan R. Synergistic effects of oncolytic reovirus and cisplatin chemotherapy in murine malignant melanoma. Clin Cancer Res 2009, 15:6158-6166. 10.1158/1078-0432.CCR-09-0796, 19773377.
26. Zheng PZ, Wang KK, Zhang QY, Huang QH, Du YZ, Zhang QH, Xiao DK, Shen SH, Imbeaud S, Eveno E, et al. Systems analysis of transcriptome and proteome in retinoic acid/arsenic trioxide-induced cell differentiation/apoptosis of promyelocytic leukemia. Proc Natl Acad Sci U S A 2005, 102:7653-7658. 1140456, 15894607, 10.1073/pnas.0502825102.
27. Ulrich-Merzenich G, Panek D, Zeitler H, Wagner H, Vetter H. New perspectives for synergy research with the "omic"-technologies. Phytomedicine 2009, 16:495-508. 10.1016/j.phymed.2009.04.001, 19428231.
28. Chen J, Zhang QR. On English Translation of JUN, CHEN, ZUO and SHI in Science of Prescription. Chinese Journal of Integrated Traditional and Western Medicine 2007, 27:946-948.
29. Kitano H, Funahashi A, Matsuoka Y, Oda K. Using process diagrams for the graphical representation of biological networks. Nat Biotechnol 2005, 23:961-966. 10.1038/nbt1111, 16082367.